Entera Bio Ltd.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. -0.77%53.580.9%$1397.83m
JNJJohnson & Johnson -0.14%179.210.7%$1294.06m
BMYBristol-Myers Squibb Co. -2.66%75.531.0%$1179.98m
MRKMerck & Co., Inc. 0.08%92.390.7%$1167.91m
ABBVAbbVie, Inc. -1.44%148.411.9%$1084.59m
LLYEli Lilly & Co. 1.84%319.231.1%$985.02m
AZNAstraZeneca Plc 0.51%67.041.0%$494.01m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 0.16%143.410.0%$493.37m
NVSNovartis AG -0.12%91.160.2%$259.56m
GSKGlaxoSmithKline Plc -1.15%43.910.2%$254.63m
VERUVeru, Inc. -0.49%12.580.0%$252.50m
HZNPHorizon Therapeutics Plc 3.67%93.925.4%$203.24m
SGENSeagen Inc. 2.32%141.675.7%$189.97m
NVONovo Nordisk A/S 0.64%107.290.1%$184.04m
VTRSViatris, Inc. 1.37%12.180.0%$167.61m

Company Profile

Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH, GLP-E, and hGh, The company was founded on September 30, 2009 and is headquartered in Jerusalem, Israel.